4Q'25 vs. 4Q'24 Results Sales: € 738.02 M (-7.1% vs. +2.0% BS(e) and +1.0% consensus); EBITDA: € 108.98 M (+3.8% vs. +1.0% BS(e) and +2.9% consensus); FY2025 vs. FY2024 Results Sales: € 3.014 Bn (-4.0% vs. -1.7% BS(e) and -2.0% consensus); EBITDA: € 420.65 M (+1.8% vs. +1.1% BS(e) and +1.6% consensus); T
4Q'25 vs. 4Q'24 Results Sales: € 13.095 Bn (+9.8% vs. +10.7% BS(e) and +11.1% consensus); EBITDA: € 853.0 M (+9.8% vs. +6.9% BS(e) and +11.6% consensus); EBIT: € 603.0 M (+18.0% vs. +17.8% BS(e) and +6.7% consensus); Net Profit: € 295.0 M (+32.3% vs. +14.3% BS(e) and +20.1% consensus); FY2025 vs. FY2024 Results Sales: € 49.848 Bn (+19.7% vs. +20.0% BS(e) and +20.1% consensus); EBITDA: € 3.07 Bn (+25.0% vs. +24.1% BS(e) and +25.6% consensus); EBIT: € 2.1 Bn (+32.1% vs. +32.0% BS(e) and +28.4% con...
4Q'25 vs. 4Q'24 Results Sales: € 474.4 M (+0.7% vs. +0.9% BS(e) and -0.2% consensus); EBITDA: € 109.1 M (+1.3% vs. +0.8% BS(e) and -0.5% consensus); FY2025 vs. FY2024 Results Sales: € 2.078 Bn (+3.2% vs. +3.3% BS(e) and +3.0% consensus); EBITDA: € 544.9 M (+2.1% vs. +2.0% BS(e) and +1.7% consensus);
4Q'25 vs. 4Q'24 Results Sales: € 2.715 Bn (+8.4% vs. +7.3% BS(e) and +0.2% consensus); EBITDA: € 426.0 M (+27.5% vs. +12.8% BS(e) and +12.0% consensus); EBIT: € 276.0 M (+305.9% vs. +293.9% BS(e) and +293.1% consensus); FY2025 vs. FY2024 Results Sales: € 9.627 Bn (+5.2% vs. +4.9% BS(e) and +3.0% consensus); EBITDA: € 1.457 Bn (+8.6% vs. +4.9% BS(e) and +4.7% consensus); EBIT: € 967.0 M (+7.3% vs. +6.4% BS(e) and +6.4% consensus);
Rdos. 4T'25 vs 4T'24: Ventas: 2.715 M euros (+8,4% vs +7,3% BS(e) y +0,2% consenso); EBITDA: 426,0 M euros (+27,5% vs +12,8% BS(e) y +12,0% consenso); EBIT: 276,0 M euros (+305,9% vs +293,9% BS(e) y +293,1% consenso); Rdos. 2025 vs 2024: Ventas: 9.627 M euros (+5,2% vs +4,9% BS(e) y +3,0% consenso); EBITDA: 1.457 M euros (+8,6% vs +4,9% BS(e) y +4,7% consenso); EBIT: 967,0 M euros (+7,3% vs +6,4% BS(e) y +6,4% consenso);
Rdos. 4T'25 vs 4T'24: Ventas: 13.095 M euros (+9,8% vs +10,7% BS(e) y +11,1% consenso); EBITDA: 853,0 M euros (+9,8% vs +6,9% BS(e) y +11,6% consenso); EBIT: 603,0 M euros (+18,0% vs +17,8% BS(e) y +6,7% consenso); BDI: 295,0 M euros (+32,3% vs +14,3% BS(e) y +20,1% consenso). Rdos. 2025 vs 2024: Ventas: 49.848 M euros (+19,7% vs +20,0% BS(e) y +20,1% consenso); EBITDA: 3.070 M euros (+25,0% vs +24,1% BS(e) y +25,6% consenso); EBIT: 2.100 M euros (+32,1% vs +32,0% BS(e) y +28,4% consenso); BDI: ...
Rdos. 4T'25 vs 4T'24: Ventas: 738,02 M euros (-7,1% vs +2,0% BS(e) y +1,0% consenso); EBITDA: 108,98 M euros (+3,8% vs +1,0% BS(e) y +2,9% consenso). Rdos. 2025 vs 2024: Ventas: 3.014 M euros (-4,0% vs -1,7% BS(e) y -2,0% consenso); EBITDA: 420,65 M euros (+1,8% vs +1,1% BS(e) y +1,6% consenso).
Rdos. 4T'25 vs 4T'24: Ventas: 474,4 M euros (+0,7% vs +0,9% BS(e) y -0,2% consenso); EBITDA: 109,1 M euros (+1,3% vs +0,8% BS(e) y -0,5% consenso). Rdos. 2025 vs 2024: Ventas: 2.078 M euros (+3,2% vs +3,3% BS(e) y +3,0% consenso); EBITDA: 544,9 M euros (+2,1% vs +2,0% BS(e) y +1,7% consenso).
NEWS SUMMARY: ACS, EBRO FOODS, FERROVIAL, INDRA, MELIÁ, NEINOR HOMES, REDEIA, SANTANDER. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’25 results to be released over the coming days in Spain. Market stabilises There was widespread recovery on European stock markets, which benefited from the better sentiment on the impact from AI and the economic cycle. In the STOXX 600, th...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.